A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients
Clinical trial NCT01330316 · COMPLETED
Trial details
- NCT number
- NCT01330316
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.